Back
CBS PREMIUM ACCESS

Pharmacological Targeting of Senescence with ABT-263 in Experimental Heart Failure with Preserved Ejection Fraction

Session: Moderated poster 10 - Heart Failure
Topic: Heart Failure
Speaker: Miss E. Silva (Porto, PT)
Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

Like

About the speaker

Miss Elsa Silva

I3s (Institute for Research and Innovation in Health), Porto (Portugal)
0 follower

4 more presentations in this session

Identification of small-molecule ERBB4 agonists for the treatment of heart failure

Speaker: Miss E. Feyen (Antwerp, BE)

Access
Abstract
Like
Thumbnail

EDEM2 regulation of cardiac lipid metabolism in heart failure with preserved ejection fraction

Speaker: Ms R. Raja (Manchester, GB)

Access
Abstract
Like
Thumbnail

Clonal hematopoiesis driven by DNMT3A mutations fuels a vicious cycle of cardiac inflammation and fibrosis in heart failure

Speaker: Ms M. Shumliakivska (Frankfurt Am Main, DE)

Access
Abstract
Like
Thumbnail

Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model

Speaker: Doctor Y. Lin (Singapore, SG)

Access
Abstract
Like
Thumbnail

Access the full session

Moderated poster 10 - Heart Failure

Speakers: Miss E. Silva, Miss E. Feyen, Ms R. Raja, Ms M. Shumliakivska, Doctor Y. Lin
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources